相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Heparan Sulfate Synthesized by Ext1 Regulates Receptor Tyrosine Kinase Signaling and Promotes Resistance to EGFR Inhibitors in GBM
Yuki Ohkawa et al.
MOLECULAR CANCER RESEARCH (2021)
UniProt: the universal protein knowledgebase in 2021
Alex Bateman et al.
NUCLEIC ACIDS RESEARCH (2021)
Machine-Learning and Chemicogenomics Approach Defines and Predicts Cross-Talk of Hippo and MAPK Pathways
Trang H. Pham et al.
CANCER DISCOVERY (2021)
Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer
Sebastian M. Dieter et al.
CELL REPORTS (2021)
A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis
Li Li et al.
GENOME BIOLOGY (2021)
Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway
Kari J. Kurppa et al.
CANCER CELL (2020)
Visualizing and interpreting cancer genomics data via the Xena platform
Mary J. Goldman et al.
NATURE BIOTECHNOLOGY (2020)
A Genome-Wide CRISPR-Cas9 Screen Reveals the Requirement of Host Cell Sulfation for Schmallenberg Virus Infection
Thiprampai Thamamongood et al.
JOURNAL OF VIROLOGY (2020)
The Hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasis
Xiaomeng Zhang et al.
ONCOGENE (2020)
SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis
John M. Lamar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Role of heparan sulfate in the Zika virus entry, replication, and cell death
Huixin Gao et al.
VIROLOGY (2019)
Anaplastic Lymphoma Kinase Confers Resistance to BRAF Kinase Inhibitors in Melanoma
Radoslav Janostiak et al.
ISCIENCE (2019)
YAP/TAZ Signaling and Resistance to Cancer Therapy
Chan D. K. Nguyen et al.
TRENDS IN CANCER (2019)
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress
Jennifer Tsoi et al.
CANCER CELL (2018)
A cell identity switch allows residual BCC to survive Hedgehog pathway inhibition
Brian Biehs et al.
NATURE (2018)
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
Yumeng Wang et al.
CELL REPORTS (2018)
The Genetic/Non-genetic Duality of Drug 'Resistance' in Cancer
Ravi Salgia et al.
TRENDS IN CANCER (2018)
Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer
Jingyu Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors
Ryan J. Park et al.
NATURE GENETICS (2017)
Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
Matthew J. Hangauer et al.
NATURE (2017)
Targeting heparin and heparan sulfate protein interactions
Ryan J. Weiss et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2017)
caRpools: an R package for exploratory data analysis and documentation of pooled CRISPR/Cas9 screens
Jan Winter et al.
BIOINFORMATICS (2016)
Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP/TAZ activation
Min Hwan Kim et al.
EMBO JOURNAL (2016)
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
John G. Doench et al.
NATURE BIOTECHNOLOGY (2016)
Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9
Gozde Korkmaz et al.
NATURE BIOTECHNOLOGY (2016)
Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance
Willy Hugo et al.
CELL (2015)
Genomic Classification of Cutaneous Melanoma
Rehan Akbani et al.
CELL (2015)
Tyrosine Sulfation as a Protein Post-Translational Modification
Yuh-Shyong Yang et al.
MOLECULES (2015)
Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
Francesca Zanconato et al.
NATURE CELL BIOLOGY (2015)
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
Luping Lin et al.
NATURE GENETICS (2015)
SLC transporters as therapeutic targets: emerging opportunities
Lawrence Lin et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
HTSeq-a Python framework to work with high-throughput sequencing data
Simon Anders et al.
BIOINFORMATICS (2015)
EPHA2 Is a Mediator of Vemurafenib Resistance and a Novel Therapeutic Target in Melanoma
Benchun Miao et al.
CANCER DISCOVERY (2015)
Colon Cancer Cells Escape 5FU Chemotherapy-Induced Cell Death by Entering Stemness and Quiescence Associated with the c-Yes/YAP Axis
Yasmine Touil et al.
CLINICAL CANCER RESEARCH (2014)
A novel panel of biomarkers predicts radioresistance in patients with squamous cell carcinoma of the head and neck
Jan Akervall et al.
EUROPEAN JOURNAL OF CANCER (2014)
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
Chong Sun et al.
NATURE (2014)
Easy quantitative assessment of genome editing by sequence trace decomposition
Eva K. Brinkman et al.
NUCLEIC ACIDS RESEARCH (2014)
THE BIOLOGY OF YAP/TAZ: HIPPO SIGNALING AND BEYOND
Stefano Piccolo et al.
PHYSIOLOGICAL REVIEWS (2014)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem et al.
SCIENCE (2014)
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
Judith Mueller et al.
NATURE COMMUNICATIONS (2014)
A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors
David J. Konieczkowski et al.
CANCER DISCOVERY (2014)
MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens
Wei Li et al.
GENOME BIOLOGY (2014)
Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3
Ethan V. Abel et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions
Daehwan Kim et al.
GENOME BIOLOGY (2013)
Targeted Disruption of Heparan Sulfate Interaction with Hepatocyte and Vascular Endothelial Growth Factors Blocks Normal and Oncogenic Signaling
Fabiola Cecchi et al.
CANCER CELL (2012)
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
Yi Liu-Chittenden et al.
GENES & DEVELOPMENT (2012)
Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR
Anirudh Prahallad et al.
NATURE (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
Michelangelo Cordenonsi et al.
CELL (2011)
Role of YAP/TAZ in mechanotransduction
Sirio Dupont et al.
NATURE (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Targeting EXT1 reveals a crucial role for heparan sulfate in the growth of multiple myeloma
Rogier M. Reijmers et al.
BLOOD (2010)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.
Makoto Maemondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Differential expression analysis for sequence count data
Simon Anders et al.
GENOME BIOLOGY (2010)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
In vivo switching of human melanoma cells between proliferative and invasive states
Keith S. Hoek et al.
CANCER RESEARCH (2008)
TEAD mediates YAP-dependent gene induction and growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2008)
Novel MITF targets identified using a two-step DNA microarray strategy
Keith S. Hoek et al.
PIGMENT CELL & MELANOMA RESEARCH (2008)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature
Keith S. Hoek et al.
PIGMENT CELL RESEARCH (2006)
Molecular cloning and characterization of a novel 3′-phosphoadenosine 5′-phosphosulfate transporter, PAPST2
S Kamiyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Identification of direct genomic targets downstream of the nuclear factor-κB transcription factor mediating tumor necrosis factor signaling
B Tian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Molecular cloning and identification of 3′- phosphoadenosine 5′-phosphosulfate transporter
S Kamiyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex
ZLL Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Divergent gene regulation and growth effects by NF-κB in epithelial and mesenchymal cells of human skin
K Hinata et al.
ONCOGENE (2003)
Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer
CL Vogel et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
分享论文
